Clinical practice regarding dopamine-agonist use and driving in Parkinson's disease.
Identifieur interne : 000848 ( Ncbi/Curation ); précédent : 000847; suivant : 000849Clinical practice regarding dopamine-agonist use and driving in Parkinson's disease.
Auteurs : R M A. De Bie [Canada] ; J. Miyasaki ; A E Lang ; S H FoxSource :
- The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques [ 0317-1671 ] ; 2007.
Descripteurs français
- Wicri :
- geographic : Canada.
English descriptors
- KwdEn :
- Automobile Driving, Canada, Disorders of Excessive Somnolence (chemically induced), Dopamine Agonists (adverse effects), Dopamine Agonists (therapeutic use), Guideline Adherence (statistics & numerical data), Guidelines as Topic, Humans, Parkinson Disease (drug therapy), Practice Patterns, Physicians' (statistics & numerical data).
- MESH :
- chemical , adverse effects : Dopamine Agonists.
- chemical , therapeutic use : Dopamine Agonists.
- geographic : Canada.
- chemically induced : Disorders of Excessive Somnolence.
- drug therapy : Parkinson Disease.
- statistics & numerical data : Guideline Adherence, Practice Patterns, Physicians'.
- Automobile Driving, Guidelines as Topic, Humans.
Abstract
Current Health Canada instructions for use of the dopamine agonists (DA), pramipexole and ropinirole, state that Parkinson's disease (PD) patients should be told not to drive. The objective was to assess neurologists' actual clinical practice concerning driving advice they give to PD patients starting a DA.
PubMed: 18062452
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001036
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :001036
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001036
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000848
Links to Exploration step
pubmed:18062452Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clinical practice regarding dopamine-agonist use and driving in Parkinson's disease.</title><author><name sortKey="De Bie, R M A" sort="De Bie, R M A" uniqKey="De Bie R" first="R M A" last="De Bie">R M A. De Bie</name><affiliation wicri:level="4"><nlm:affiliation>Movement Disorders Centre, Division of Neurology University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Movement Disorders Centre, Division of Neurology University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Miyasaki, J" sort="Miyasaki, J" uniqKey="Miyasaki J" first="J" last="Miyasaki">J. Miyasaki</name></author><author><name sortKey="Lang, A E" sort="Lang, A E" uniqKey="Lang A" first="A E" last="Lang">A E Lang</name></author><author><name sortKey="Fox, S H" sort="Fox, S H" uniqKey="Fox S" first="S H" last="Fox">S H Fox</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2007">2007</date><idno type="RBID">pubmed:18062452</idno><idno type="pmid">18062452</idno><idno type="wicri:Area/PubMed/Corpus">001036</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001036</idno><idno type="wicri:Area/PubMed/Curation">001036</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001036</idno><idno type="wicri:Area/PubMed/Checkpoint">001036</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001036</idno><idno type="wicri:Area/Ncbi/Merge">000848</idno><idno type="wicri:Area/Ncbi/Curation">000848</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Clinical practice regarding dopamine-agonist use and driving in Parkinson's disease.</title><author><name sortKey="De Bie, R M A" sort="De Bie, R M A" uniqKey="De Bie R" first="R M A" last="De Bie">R M A. De Bie</name><affiliation wicri:level="4"><nlm:affiliation>Movement Disorders Centre, Division of Neurology University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Movement Disorders Centre, Division of Neurology University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Miyasaki, J" sort="Miyasaki, J" uniqKey="Miyasaki J" first="J" last="Miyasaki">J. Miyasaki</name></author><author><name sortKey="Lang, A E" sort="Lang, A E" uniqKey="Lang A" first="A E" last="Lang">A E Lang</name></author><author><name sortKey="Fox, S H" sort="Fox, S H" uniqKey="Fox S" first="S H" last="Fox">S H Fox</name></author></analytic><series><title level="j">The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques</title><idno type="ISSN">0317-1671</idno><imprint><date when="2007" type="published">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Automobile Driving</term><term>Canada</term><term>Disorders of Excessive Somnolence (chemically induced)</term><term>Dopamine Agonists (adverse effects)</term><term>Dopamine Agonists (therapeutic use)</term><term>Guideline Adherence (statistics & numerical data)</term><term>Guidelines as Topic</term><term>Humans</term><term>Parkinson Disease (drug therapy)</term><term>Practice Patterns, Physicians' (statistics & numerical data)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Dopamine Agonists</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Dopamine Agonists</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Canada</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Disorders of Excessive Somnolence</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Guideline Adherence</term><term>Practice Patterns, Physicians'</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Automobile Driving</term><term>Guidelines as Topic</term><term>Humans</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Current Health Canada instructions for use of the dopamine agonists (DA), pramipexole and ropinirole, state that Parkinson's disease (PD) patients should be told not to drive. The objective was to assess neurologists' actual clinical practice concerning driving advice they give to PD patients starting a DA.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000848 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000848 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Ncbi
|étape= Curation
|type= RBID
|clé= pubmed:18062452
|texte= Clinical practice regarding dopamine-agonist use and driving in Parkinson's disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:18062452" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |